Fresh Tracks Therapeutics, Inc. (FRTX)

Fresh Tracks Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-5.69	-20.66	-39.52	-20.9	-25.95
Depreciation & Amortization	0.04	0.03	0.02	0.01	0.03
Share-Based Compensation	1.92	2.16	2.26	1.99	1.53
Other Operating Activities	-0.61	-0.86	1.09	-1.13	-11.6
Operating Cash Flow	-4.34	-19.34	-36.15	-20.03	-35.98
Capital Expenditures	0	-0.05	-0.04	-0.02	-0.01
Change in Investments	-	-	-	-4.5	-19.5
Other Investing Activities	-	-	-	9	52.02
Investing Cash Flow	0	-0.05	-0.04	4.48	32.51
Common Stock Issued	6.57	1.2	24.01	37.98	0
Share Repurchases	0	0.04	-0.05	0	0
Other Financing Activities	-0.04	0.02	8.9	0.46	2.64
Financing Cash Flow	6.53	1.18	32.95	38.44	2.64
Net Cash Flow	2.19	-18.2	-3.23	22.88	-0.84
Free Cash Flow	-4.34	-19.38	-36.18	-20.06	-35.99
Free Cash Flow Margin	-54.25%	-279.16%	-8956.44%	-1100.82%	-454.57%
Free Cash Flow Per Share	-0.73	-6.90	-20.27	-36.82	-535.71

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.